JPRN-UMIN000003438已完成未知
Cinacalcet and concurrent intravenous calcitriol for treatment of secondary hyperparathyroidism in dialysis patients compared with intravenous calcitriol alone - Comparison of cinacalcet and concurrent intravenous calcitriol with calcitriol alone
1.Division of Internal medicine, Seseragi hospital 2.Department of Medicine & Biological Science Gunma University Graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2010年4月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional,observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.severe liver dysfunction or cirrhosis 2.parathyroidectomy within the previous 24 weeks 3.patients receiving or likely to use within 52 weeks of corticosteroid except for external use 4.use of bisphosphonate 5.pregnant or nursing 6.unsuitable patients
研究者
相似试验
已完成
不适用
Cinacalcet for the treatment of hypercalcemia with persistent hyperparathyroidism in renal transplant recipients: a case siries study.Hypercalcemia with persistent hyperparathyroidism in renal transplant recipients.JPRN-UMIN000003236St Marianna University15
已完成
4 期
Efficacy and safety of treatment with Cinacalcet in patients with Primary Hyperparathyroidism due to a MEN-1 mutatioprimary hyperparathyroidismhyperactive parathyroid glands1008362410033949NL-OMON34871eids Universitair Medisch Centrum20
已完成
不适用
A combination of cinacalcet with maxacalcitol for regression of moderate to advanced secondary hyperparathyroidism in patients on chronic hemodialysissecondary hyperparathyroidismJPRN-UMIN000001478Kitano Hospital Division of Nephrology and Dialysis50
招募中
不适用
Effects of etelcalcetide and cinacalcet for the vascular carcification in hemodialysis patients with secondary hyperparathyroidismHemodialysis patients complicated with secondary hyperparathyroidismJPRN-UMIN000027454Matsunami general hospital30
进行中（未招募）
不适用
Efficacy and safety of the calcimimetic Cinacalcet in the management of patients with Primary Hyperparathyroidism due to a MEN-1 mutation - Cinacalcet in MEN-I PHPTPatients with primary hyperparathyroidism due to a germline mutation in the MEN-1 geneMedDRA version: 12.1Level: LLTClassification code 10036693Term: Primary hyperparathyroidismEUCTR2010-018861-53-NLeiden University Medical Center